TWC
DRTS icon

TD Waterhouse Canada’s Alpha Tau Medical DRTS Stock Holding History

TD Waterhouse Canada’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Hold
2,568
– – ﹤0.01% 1619
2025
Q4 		$12.6K Hold
2,568
– – ﹤0.01% 1496
2025
Q3 		$11.1K Buy
+2,568
New +$8.74K ﹤0.01% 1516

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

TD Waterhouse Canada's DRTS Position: Q1 2026 in Review

TD Waterhouse Canada held its Alpha Tau Medical (DRTS) position steady in Q1 2026 at 2,568 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

TD Waterhouse Canada first reported a position in DRTS in Q3 2025 and has held it in 3 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • TD Waterhouse Canada held 2,568 shares of Alpha Tau Medical worth $17.6K as of Q1 2026.
  • TD Waterhouse Canada left its Alpha Tau Medical share count unchanged in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1619 holding.
  • TD Waterhouse Canada first reported a position in Alpha Tau Medical in Q3 2025 and has held it in 3 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.